10,722 reports of this reaction
5.8% of all BUPRENORPHINE reports
#4 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #4 most commonly reported adverse reaction for BUPRENORPHINE, manufactured by Purdue Pharma LP. There are 10,722 FDA adverse event reports linking BUPRENORPHINE to TOXICITY TO VARIOUS AGENTS. This represents approximately 5.8% of all 185,849 adverse event reports for this drug.
Patients taking BUPRENORPHINE who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is moderately reported among BUPRENORPHINE users, representing a notable but not dominant share of adverse events.
In addition to toxicity to various agents, the following adverse reactions have been reported for BUPRENORPHINE:
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 10,722 FDA reports for BUPRENORPHINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 5.8% of all adverse event reports for BUPRENORPHINE, making it a notable side effect.
If you experience toxicity to various agents while taking BUPRENORPHINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.